Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes
Abstract Tuberculosis (TB) is considered as one of the most serious threats to public health in many parts of the world. The threat is even more severe in the developing countries where there is a lack of advanced medical amenities and contemporary anti-TB drugs. In such situations, dosage optimizat...
Main Authors: | Yuhui Xu, Jianan Wu, Sha Liao, Zhaogang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Annals of Clinical Microbiology and Antimicrobials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12941-017-0239-4 |
Similar Items
-
Complications leading to hospitalization due to consumption of anti-TB drugs in patients with tuberculosis in Gorgan, Iran (2007-12)
by: Khodabakhshi B, et al.
Published: (2014-10-01) -
Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
by: Mabhula, Amanda N
Published: (2021) -
Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018
by: Mariana Buziashvili, et al.
Published: (2021-01-01) -
Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis
by: Parvaneh Baghaei, et al.
Published: (2015-01-01) -
3D host cell and pathogen-based bioassay development for testing anti-tuberculosis (TB) drug response and modeling immunodeficiency
by: Mukundan Shilpaa, et al.
Published: (2021-09-01)